2 terminated, 1 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Terminated 2, Completed 1 |
Follow Radionetics Oncology: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1 Study of 68Ga-R11228 and 177Lu-R11228 in Breast Cancer 68Ga-R11228, 177Lu-R11228 - Locoregionally Recurrent Hormone-receptor Positive Breast Cancer, Metastatic Hormone Receptor Positive Breast Cancer | Phase 1 | Terminated | Radionetics Oncology | 11 | 2025-10-01 | 2026-07-13 |
| Study of 68Ga-R10602 68Ga-R10602 injection - Locoregionally Recurrent Hormone-receptor Positive Breast Cancer, Metastatic Hormone Receptor Positive Breast Cancer | Phase 1 | Completed | Radionetics Oncology | 27 | 2024-12-10 | 2026-07-06 |
| Phase 1 Study of 68Ga-R8760 68Ga-R8760 injection at pre-defined dose levels, 68Ga-R8760 injection - Adrenocortical Carcinoma | Phase 1 | Terminated | Radionetics Oncology | 11 | 2023-09-11 | 2024-12-09 |
United States (3) · Australia (1)